FDA NDC Directory · JSON-LD · Markdown

Testosterone

NDC 0591-2926 · HUMAN PRESCRIPTION DRUG · GEL

Labeler / ManufacturerActavis Pharma, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA204570
Dosage form / routeGEL · TRANSDERMAL
Active ingredientsTESTOSTERONE (16.2 mg/g)
Marketing started20210212
Package count1

External sources

Source: openFDA. Public-domain (CC0).